ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

12,075Medicare Part D Prescriptions Filled, Including Refills

Rank: 184 out of 939

$498K Total Retail Price of All Prescriptions

Rank: 246 out of 939

477 Patients Receiving at Least One Drug in Part D
77%Patients 65 Years and Older
58% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Arkansas
Lower avg

Schedule Two
Controlled Substances

3% of this provider’s 477 patients filled at least one prescription for a schedule two drug, compared to an average of 5%.

Schedule Three
Controlled Substances

15% of this provider’s 477 patients filled at least one prescription for a schedule three drug, compared to an average of 19%.

Risky Drugs to Seniors

3% of this provider’s 9,462 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

21% of this provider’s prescriptions were for brand-name drugs, compared to an average of 21%.

Prescription Price

$41 was the average price of a prescription from this provider, compared to $49 among peers.

Prescriptions per Patient

25 is the average number of prescriptions (including refills) per patient, compared to an average of 22.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Arkansas
AMLODIPINE BESYLATE 438 386 1 6
OMEPRAZOLE 422 329 2 5
SIMVASTATIN 400 336 3 2
PRAVASTATIN SODIUM 361 277 4 13
LEVOTHYROXINE SODIUM 328 256 5 4
HYDROCODONE-ACETAMINOPHEN 293 194 S3 6 1
METFORMIN HCL 291 226 7 8
MELOXICAM 273 201 8 14
METOPROLOL TARTRATE 271 227 9 10
LISINOPRIL 255 173 10 3
GABAPENTIN 251 176 11 11
FUROSEMIDE 217 178 12 7
LOSARTAN POTASSIUM 196 164 13 29
CITALOPRAM HBR 193 145 14 15
WARFARIN SODIUM 181 142 15 17
HYDROCHLOROTHIAZIDE 173 135 16 12
POTASSIUM CHLORIDE 170 135 17 9
METOPROLOL SUCCINATE 167 145 18 21
PAROXETINE HCL 167 119 18 70
ATENOLOL 148 142 20 19
TRAMADOL HCL 148 96 20 16
CLOPIDOGREL 147 122 22 28
GLIMEPIRIDE 143 102 23 37
ZOLPIDEM TARTRATE 136 81 24 20
NEXIUM 133 89 25 18
ESTRADIOL 119 69 R 26 79
RANITIDINE HCL 107 66 27 35
PLAVIX 103 87 28 48
ZETIA 94 94 29 103
SERTRALINE HCL 93 66 30 24
CYCLOBENZAPRINE HCL 93 39 R 30 36
ALLOPURINOL 91 67 32 31
NAMENDA 89 89 33 49
DIOVAN 89 70 33 50
KLOR-CON M20 89 82 33 90
FLUOXETINE HCL 88 67 36 47
LISINOPRIL-HYDROCHLOROTHIAZIDE 83 74 37 23
LOSARTAN-HYDROCHLOROTHIAZIDE 83 73 37 55
CLONIDINE HCL 81 61 39 39
FLUTICASONE PROPIONATE 79 76 40 43
ISOSORBIDE MONONITRATE ER 76 73 41 53
TRIAMTERENE-HCTZ 74 67 42 33
VERAPAMIL ER 74 60 42 85
AMOX TR-POTASSIUM CLAVULANATE 73 50 44 144
CIPROFLOXACIN HCL 72 57 45 54
ATORVASTATIN CALCIUM 72 65 45 22
CRESTOR 71 70 47 34
POLYETHYLENE GLYCOL 3350 71 34 47 57
SUCRALFATE 69 55 49 96
PANTOPRAZOLE SODIUM 68 63 50 66
RISPERIDONE 68 68 50 82
LOVASTATIN 67 55 52 46
EVISTA 66 56 53 122
DIOVAN HCT 65 55 54 74
CYMBALTA 65 26 54 44
AZITHROMYCIN 65 53 54 32
SULFAMETHOXAZOLE-TRIMETHOPRIM 65 49 54 64
DIGOXIN 64 63 58 45
ALENDRONATE SODIUM 62 56 59 40
FLUCONAZOLE 60 37 60 140
ROPINIROLE HCL 58 51 61 78
LANTUS 58 49 61 59
FENTANYL 57 51 S2 63 104
PROPRANOLOL HCL 56 46 64 117
AMITRIPTYLINE HCL 53 53 R 65 38
QUINAPRIL HCL 52 52 66 133
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on March 5, 2013.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.